Letter to the editor: Does a "false negative" MIBG scan predict a better outcome in neuroblastoma patients?

Medical and Pediatric Oncology

Volumn 37, Issue 2, 2001, Pages 155-

  Chan, G C F ^a,b,c,d,e   Leung, Y L ^a   Shing, M M K ^a   Luk, C W ^b   Ling, S C ^c   Lee, A C W ^d  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^d PRINCESS MARGARET HOSPITAL   (Hong Kong)

^e TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE I 131; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

CANCER STAGING; CANCER SURVIVAL; HUMAN; LABORATORY DIAGNOSIS; LETTER; NEUROBLASTOMA; PRIORITY JOURNAL; SCINTISCANNING; CHILD; NOTE; PATHOLOGY; PROGNOSIS; SURVIVAL;

3-IODOBENZYLGUANIDINE; CHILD; FALSE NEGATIVE REACTIONS; HUMANS; NEUROBLASTOMA; PROGNOSIS; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; SURVIVAL ANALYSIS;

EID: 0034908089     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.1190     Document Type: Letter

References (4)

1. False-Negative Metaiodobenzylguanidine Scintigraphy at diagnosis of neuroblastoma
2. Pitfalls and solutions in neuroblastoma diagnosis using radioiodine MIBG: Our experience about 50 cases
3. Diagnostic and therapeutic possibilities of meta-iodobenzylguanidine in neuroblastoma
4. Metastatic neuroblastoma in children older than one year: Prognostic significance of initial metaiodobenzylguanidine scan and proposal for a scoring system